Compliance & Validation — Documented
HIPAA
Real-world data and evidence platform built on exclusive clinical registry partnerships with medical societies.
Verana Health, founded in 2018 and headquartered in San Francisco, transforms real-world clinical data into research-grade datasets and evidence for life sciences. Through exclusive data partnerships with medical specialty societies spanning ophthalmology, neurology, and urology registries, it curates de-identified patient data and applies analytics and NLP to support trial feasibility, patient identification, and real-world evidence generation.
100% — Complete coverage. Coverage score — how completely Atlas documents Verana Health across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
HIPAA
cloud
Data license + platform fee
3–6 months
Mid-Size Biotech, Large Pharma, Top 20 Pharma, R&D Leadership, Medical Affairs, Commercial, Data Management, Clinical Operations
Natural Language Processing, Patient Recruitment, Real-World Evidence
Series E, $288M raised, 180+ employees, Founded 2018
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Verana Health and the American Academy of Ophthalmology launched the Verana Research Network, an IRIS Registry initiative in which academic medical centers and ophthalmology practices use IRIS Registry data and Verana's platform to increase clinical trial access, accelerate recruitment, and advance ophthalmic research.
press release (Verana Health) · 2022-12-07 — Partner: American Academy of Ophthalmology